
Stargardt drug trial begins
Belite Bio announced it has completed enrolment for its pivotal global phase 3 DRAGON trial of oral treatment Tinlarebant for patients with Stargardt disease. Tinlarebant is a novel oral therapy

Belite Bio announced it has completed enrolment for its pivotal global phase 3 DRAGON trial of oral treatment Tinlarebant for patients with Stargardt disease. Tinlarebant is a novel oral therapy


Designed for faces with delicate features and great style ambitions, the Nifties collection is available in sizes 44-49, offering small frames with perfectly proportioned shapes, matching temple lengths in mature and sophisticated styles.

New Zealand researchers are launching a long-Covid registry to get an accurate picture of the country’s post-pandemic burden.

The passing of the Therapeutic Products Bill marks the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years, said health minister Dr Ayesha Verrall.

Paul McCartney recently confirmed he's a fan of eye yoga.

In an announcement, the Royal New Zealand Foundation of the Blind board chair Clive Lansink said John Mulka, chief executive of the foundation’s executive arm Blind Low Vision NZ (BLVNZ), has been replaced by BLVNZ’s current chief financial officer, Greg Hurn.

The New Zealand Association of Optometrists (NZAO) is hosting its very first peer-support conference for hospital optometrists on 2 September at the Rydges Wellington Airport hotel.

Meticulously designed and reimagined, the Victoria Beckham 2023 sunglass and optical collection reaffirms the brand’s hallmark style through bold, statement silhouettes. Crafted in Italy, sculptural acetate and rich gradient lenses offer a modern take on classic eyewear silhouettes.

JF Rey’s latest kids’ collection brings exclusive colours and distinctive designs in optical and sun revealing style and originality for children aged 4-16 years. A nod to the creative spirit of the house, the kids’ and teens’ models adopt the stylistic codes of JF Rey’s adult ranges. All models are

In the six years since publication of the evidence-based TFOS DEWS II reports¹, awareness and acknowledgement of dry eye disease (DED) as a growing global concern has continued to intensify. These reports reached consensus with respect to the diagnosis, classification, diagnosis and management of DE

In a world first, ophthalmologists at Flinders University, South Australia, will trial an early-intervention laser treatment designed to treat people at high risk of losing sight from glaucoma.